STOCK TITAN

Shareholder plans 606,312 PACB (NASDAQ: PACB) share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A PACB shareholder filed a notice to sell 606,312 common shares under Rule 144. The planned sale through Morgan Stanley Smith Barney LLC has an aggregate market value of $955,547.71 and is targeted around 02/17/2026 on the NASDAQ exchange.

The shares were acquired as restricted stock from the issuer on 02/15/2026. The notice states that the seller does not know of any undisclosed material adverse information about PACB’s current or prospective operations. PACB had 301,907,431 shares outstanding at the time referenced.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does PACB’s latest Form 144 filing disclose?

PACB’s Form 144 discloses a planned sale of 606,312 common shares. The filing shows an intended Rule 144 sale via Morgan Stanley Smith Barney LLC, with an aggregate market value of $955,547.71 and trading expected on NASDAQ around 02/17/2026.

How many PACB (PACB) shares are planned for sale under Rule 144?

The filing covers a proposed sale of 606,312 PACB common shares. These shares were acquired as restricted stock from the issuer on 02/15/2026, and are planned to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ market.

What is the aggregate market value of the PACB shares in this Form 144?

The aggregate market value of the PACB shares is $955,547.71. This value corresponds to 606,312 common shares planned for sale under Rule 144 through Morgan Stanley Smith Barney LLC, with trading expected on NASDAQ around 02/17/2026.

Who is the broker for the PACB (PACB) Rule 144 share sale?

The planned PACB share sale will use Morgan Stanley Smith Barney LLC as broker. The filing lists their Executive Financial Services unit at One New York Plaza as handling the 606,312-share Rule 144 transaction on the NASDAQ exchange.

When were the PACB shares being sold under Form 144 originally acquired?

The PACB shares were acquired on 02/15/2026 as restricted stock. The Form 144 indicates the securities were obtained directly from the issuer as restricted stock, and the same date is listed as the date of payment, marked as not applicable for cash.

How many PACB (PACB) shares were outstanding according to the Form 144 data?

The data shows 301,907,431 PACB shares outstanding. This outstanding share figure provides context for the planned Rule 144 sale of 606,312 common shares, which are intended to be sold on NASDAQ via Morgan Stanley Smith Barney LLC.
Pacific Biosc

NASDAQ:PACB

PACB Rankings

PACB Latest News

PACB Latest SEC Filings

PACB Stock Data

516.26M
299.52M
Medical Devices
Laboratory Analytical Instruments
Link
United States
MENLO PARK